| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/24/2003 | WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation |
| 12/24/2003 | WO2003082340B1 Injectable veterinary composition for small animals |
| 12/24/2003 | WO2003079020A3 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer |
| 12/24/2003 | WO2003077892A3 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases |
| 12/24/2003 | WO2003076414A3 Aryl substituted pyrimidines and the use thereof |
| 12/24/2003 | WO2003075926A8 Use of proton pump inhibitors for the treatment of airway disorders |
| 12/24/2003 | WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/24/2003 | WO2003074529A3 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS |
| 12/24/2003 | WO2003074025A3 Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 12/24/2003 | WO2003073097A9 Methods for isolating ligands e.g. t cell epitopes |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/24/2003 | WO2003070182A3 Sodium channel blockers |
| 12/24/2003 | WO2003070180A3 Compositions and methods for delivery of skin cosmeceuticals |
| 12/24/2003 | WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 12/24/2003 | WO2003068725A3 Process for the preparation of 4-hetero-substituted phenylalanine derivatives |
| 12/24/2003 | WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
| 12/24/2003 | WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 12/24/2003 | WO2003066097A3 A novel target to inhibit angiogenesis |
| 12/24/2003 | WO2003063831A3 Immediate release dosage forms containing solid drug dispersions |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 12/24/2003 | WO2003061653A9 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 12/24/2003 | WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 12/24/2003 | WO2003050251A3 Hematopoietic cells from human embryonic stem cells |
| 12/24/2003 | WO2003048148A9 Statin-like compounds |
| 12/24/2003 | WO2003045429A3 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 12/24/2003 | WO2003040174A3 Substituted amino ketone compounds |
| 12/24/2003 | WO2003037296A3 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 12/24/2003 | WO2003032963A3 Method of reducing type 2 diabetes in high risk patients |
| 12/24/2003 | WO2003028701A3 Liposomes containing (ether)lysolecithins |
| 12/24/2003 | WO2003020280B1 Compositions and use thereof in the treatment of cancer |
| 12/24/2003 | WO2003018626A3 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 12/24/2003 | WO2003011230A3 Modified reoviral therapy |
| 12/24/2003 | WO2003000196A3 Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof |
| 12/24/2003 | WO2002100858A8 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 12/24/2003 | WO2002081703A3 Mitogenic oxygenase regulators |
| 12/24/2003 | WO2002058692A3 Halogenated composition, method for preparing same and uses thereof |
| 12/24/2003 | WO2002038730A3 Novel human potassium channel beta subunit |
| 12/24/2003 | WO2002034204A8 Calcilytic compounds |
| 12/24/2003 | WO2001085193A8 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 12/24/2003 | WO2001052878A8 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 12/24/2003 | CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore |
| 12/24/2003 | CN1463269A Phenylpiperazine |
| 12/24/2003 | CN1463192A Herb compsns. for treating dopy and agrypnia |
| 12/24/2003 | CN1131870C 新的吡咯磺酰胺化合物 The new pyrrole sulfonamide compound |
| 12/24/2003 | CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine |
| 12/24/2003 | CN1131865C 作为选择性COX－2抑制剂的取代的咪唑并[1,2a]吖嗪 Substituted imidazole as selective COX-2 inhibitors and [1,2a] azines |
| 12/24/2003 | CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate |
| 12/24/2003 | CN1131858C 旋光的氨基戊烷衍生物 Aminopentane optically active derivatives |
| 12/24/2003 | CN1131856C 作为黄体酮受体调节剂的环硫代氨基甲酸酯衍生物 As cyclic thiocarbamate derivative of progesterone receptor modulators |
| 12/24/2003 | CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 12/24/2003 | CA2489870A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | CA2489791A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of anxiety or depression |
| 12/24/2003 | CA2489726A1 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | CA2489605A1 Oxaliplatin anti-resistance agent |
| 12/24/2003 | CA2489470A1 Prodrug and process for producing the same |
| 12/24/2003 | CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | CA2489440A1 Anti-igf-i receptor antibody |
| 12/24/2003 | CA2489367A1 Compounds, compositions, and methods |
| 12/24/2003 | CA2489361A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 12/24/2003 | CA2489312A1 Modulation of activation of glucocorticoid receptors .beta.-breakdown products of glucocorticoids |
| 12/24/2003 | CA2489286A1 2-naphtamide derivatives |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489247A1 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 12/24/2003 | CA2489179A1 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | CA2488880A1 Quinone-based therapeutic agent for hepatopathy |
| 12/24/2003 | CA2488842A1 Carbocyclic nucleoside analogs as rna-antivirals |
| 12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | CA2488699A1 Indole, indazole, and benzazole derivative |
| 12/24/2003 | CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid |
| 12/24/2003 | CA2488138A1 Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent |
| 12/24/2003 | CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | CA2487809A1 Aptamer-toxin molecules and methods for using same |
| 12/24/2003 | CA2487122A1 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 12/24/2003 | CA2486215A1 Mitotic kinesin inhibitors |
| 12/24/2003 | CA2485751A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions |
| 12/24/2003 | CA2485346A1 Human adam-10 inhibitors |
| 12/24/2003 | CA2477878A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/23/2003 | US6667404 Retroviral protease inhibiting compounds |
| 12/23/2003 | US6667342 Benzenesulfonamide-derivatives and their use as medicaments |
| 12/23/2003 | US6667336 Phenyl-thienyl-prop-1-en-3-yl-sarcosine derivatives; nontoxic; neurological and neuropsychiatric disorders; glycine transporter sequestering |
| 12/23/2003 | US6667335 NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers |
| 12/23/2003 | US6667328 Such as 2-(N-Cyanoimino)-5-((E)-4-styrylbenzylidene)thiazol-idin-4-one; prophylaxis of hypolipidemic/hypoglycemic, hyper-/hypo-cholesterolemia activity |
| 12/23/2003 | US6667327 Pyridine amido derivatives |
| 12/23/2003 | US6667325 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases |
| 12/23/2003 | US6667320 For therapy of infalmmation; asthma, cancer, arthritis, multiple sclerosis; prophylaxis of infection of target cells by a human immunodeficiency virus (HIV) |
| 12/23/2003 | US6667317 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| 12/23/2003 | US6667316 Pharmaceutically active isoindoline derivatives |
| 12/23/2003 | US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates) |
| 12/23/2003 | US6667313 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators |
| 12/23/2003 | US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide |
| 12/23/2003 | US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 12/23/2003 | US6667300 Purinyl substituted quinazoline-4-one derivatives |
| 12/23/2003 | US6667064 Composition and method for treatment of hypertriglyceridemia |
| 12/23/2003 | US6667053 D and L etherlipid stereoisomers and liposomes |
| 12/23/2003 | US6667035 Isolated polypeptide which specifically binds and neutralizes Clostridium difficile enterotoxin (toxin A) |
| 12/23/2003 | CA2268439C Citrus peel extract as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor |